BioNotebook: Xoma, Endo, Adamis, CymaBay, Theratechnologies

Xoma offering will gross $50m; Endo sells notes to refinance debt; Adamis splits stock, raises $22.1m; CymaBay closes $38.2m in financing; and Theratechnologies regains Egrifta.

More from Alimentary/Metabolic

More from Therapy Areas